Vicarious Surgical (RBOT) Asset Writedowns and Impairment (2022 - 2025)
Vicarious Surgical's (RBOT) quarterly Asset Writedowns and Impairment came in at $253000.0 in Q3 2025, up 11.45% year-on-year from $227000.0 in Q3 2024, and up 2.85% on a QoQ basis from $246000.0 in Q2 2025.
Vicarious Surgical (RBOT) Asset Writedowns and Impairment (2022 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 4 years of Asset Writedowns and Impairment data on file, last reported at $253000.0 in Q3 2025.
- On a quarterly basis, Asset Writedowns and Impairment rose 11.45% year-over-year to $253000.0 in Q3 2025; TTM through Sep 2025 was $972000.0, a 11.09% increase from a year earlier, with the FY2024 full-year figure at $899000.0, up 10.44% from the prior year.
- Asset Writedowns and Impairment for Q3 2025 stood at $253000.0, up from $246000.0 in the prior quarter.
- Over the last five years, Asset Writedowns and Impairment for RBOT reached as high as $253000.0 in Q3 2025 and fell as low as $193000.0 in Q4 2022.
- Historically, Asset Writedowns and Impairment has averaged $218666.7 across 4 years, with a median of $217000.0 in 2022.
- Across the five-year window, Asset Writedowns and Impairment fell 9.68% in 2023 and climbed 11.45% in 2025, its largest moves.
- Year by year, Asset Writedowns and Impairment stood at $193000.0 in 2022, then rose by 8.81% to $210000.0 in 2023, then gained by 11.43% to $234000.0 in 2024, then advanced by 8.12% to $253000.0 in 2025.
- Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were $253000.0 in Q3 2025, $246000.0 in Q2 2025, and $239000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 253,000.00 |
| Sep 30, 2025 | 253,000.00 |
| Jun 30, 2025 | 246,000.00 |
| Jun 30, 2025 | 246,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Mar 31, 2025 | 239,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Sep 30, 2024 | 227,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Jun 30, 2024 | 222,000.00 |
| Mar 31, 2024 | 216,000.00 |
| Mar 31, 2024 | 216,000.00 |
| Dec 31, 2023 | 210,000.00 |
| Dec 31, 2023 | 210,000.00 |
| Sep 30, 2023 | 207,000.00 |
| Sep 30, 2023 | 207,000.00 |
| Jun 30, 2023 | 201,000.00 |
| Jun 30, 2023 | 201,000.00 |